HealthStream (HSTM) Q2 2024 earnings summary

Executive summary

• Q2 2024 revenue grew 3.4% year-over-year to $71.6 million, with net income up 0.8% to $4.2 million and operating income up 10.1% to $4.4 million.

• Adjusted EBITDA rose 3.3% to $15.8 million, with a margin of 22.1%, despite a $1 million charge from a customer bankruptcy.

• 96% of revenues are subscription-based, with contracts averaging 3–5 years, providing predictable recurring revenue.

• Profitable, with no interest-bearing debt and cash and marketable securities totaling $83 million as of June 30, 2024.

• Focused on SaaS-based platform growth, with strong sales pipeline and continued investment in platform integration and new markets.

Financial highlights

• Q2 2024 revenue was $71.6 million, up 3.4% year-over-year; six-month revenue was $144.3 million, up 4% year-over-year.

• Net income for Q2 2024 was $4.2 million; EPS was $0.14, up from $0.13; YTD net income was $9.4 million.

• Adjusted EBITDA for Q2 2024 was $15.8 million; YTD adjusted EBITDA was $32.9 million.

• Free cash flow improved 20% to $12.9 million; cash and investments at $83 million.

• Product development expenses rose 9% to $12.1 million in Q2 2024, mainly due to higher labor costs.

Outlook and guidance

• 2024 revenue guidance reiterated at $292–$296 million, with net income expected between $16.7–$18.6 million and adjusted EBITDA between $64.5–$67.5 million.

• Sequential quarterly revenue growth expected in the second half, driven by backlog conversion and strong bookings.

• Guidance assumes stable economic conditions and excludes impacts from potential acquisitions or asset impairments.

• Management expects existing cash, marketable securities, and available credit to be sufficient for at least the next 12 months.